Lipopolysaccharide depresses cardiac contractility and β-adrenergic contractile response by decreasing myofilament response to Ca2+ in cardiac myocytes

Circulation Research

Volumn 81, Issue 6, 1997, Pages 1011-1020

  Yasuda, Satoshi ^a   Lew, Wilbur Y W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Ca2+; Lipopolysaccharide; Myofilament; Nitric oxide synthase; adrenergic receptor agonist

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM; ISOPRENALINE; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; BETA ADRENERGIC STIMULATION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEMODYNAMICS; MEDIATOR RELEASE; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; RABBIT; SECOND MESSENGER; TISSUE PERFUSION;

EID: 0030778084     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.6.1011     Document Type: Article

References (44)

1. Bone RC. The pathogenesis of sepsis. Ann Intern Med. 1991;115: 457-469.
2. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med. 1994;120:771-783.
3. Hung J, Lew WYW. Temporal sequence of endotoxin-induced systolic and diastolic myocardial depression in rabbits. Am J Physiol. 1993:265:H810-H819.
4. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993;328:1471-1477.
5. Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol. 1995;27:155-167.
6. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363-380.
7. Nishikawa Y, Lew WYW. Serum tumor necrosis factor-α does not mediate endotoxin-induced myocardial depression in rabbits. Am J Physiol. 1996;270:H485-H491.
8. Tao S, McKenna TM. In vitro endotoxin exposure induces contraclile dysfunction in adult rat cardiac myocytes. Am J Physiol. 1994;267:H1745-H1752.
9. Silverman HJ, Penaranda R, Orens JB, Lee NH. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med. 1993;21:31-39. Comments.
10. Gulick T, Cluing MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte betaadrenergic responsiveness. Proc Natl Acad Sci U S A. 1989;86:6753-6757.
11. Chung MK, Gulick TS, Rotondo RE, Schreiner GF, Lange LG. Mechanism of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: impairment of signal transduction. Circ Res. 1990;67:753-763.
12. Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 1993;91:2314-2319.
13. Luss H, Watkins SC, Freeswick PD, Imro AK, Nussler AK, Billiar TR, Simmons RL, del Nido PJ, McGowan FX Jr. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol. 1995;27:2015-2029.
14. LaPointe MC, Sitkins JR. Mechanisms of interleukin-1beta regulation of nitric oxide synthase in cardiac myocytes. Hypertension. 1996;27:709-714.
15. Hung J, Lew WYW. Cellular mechanisms of endotoxin-induced myocardial depression in rabbits. Circ Res. 1993;73:125-134.
16. Pfitzer G, Ruegg JC, Flockerzi V, Hofmann F. cGMP-dependent protein kinase decreases calcium sensitivity of skinned cardiac fibers. FEBS Lett. 1982;149:171-175.
17. 2+ in intact cardiac myocytes. Circ Res. 1994;74:970-978.
18. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771-778.
19. Virca GD, Kim SY, Glaser KB, Ulevitch RJ. Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J Biol Chem. 1989;264:21951-21956.
20. Ziegler-Heitbrock HW. Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm. 1995;45:13-26.
21. Aida Y, Pabst MJ. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods. 1990;132:191-195.
22. Lew WYW, Lee M, Yasuda S, Bayna E. Depyrogenation of digestive enzymes reduces lipopolysaccharide tolerance in isolated cardiac myocytes. J Mol Cell Cardiol 1997;29:1985-1990.
23. Cheung JY, Tillotson DL, Yelamarty RV, Scaduto RC. Cytosolic free calcium concentration in individual cardiac myocytes in primary culture. Am J Physiol. 1989;256:C1120-C1130.
24. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
25. Altschuld RA, Wenger WC, Lamka KG, Kindig OR, Capen CC, Mizuhira V, Vander Heide RS, Brierley GP. Structural and functional properties of adult rat heart myocytes lysed with digitonin. J Biol Chem. 1985;260:14325-14334.
26. Bassani JW, Bassani RA, Bers DM. Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J Physiol (Lond).1994;476:279-293.
27. i in intact rabbit cardiac myocytes. Biophys J. 1995;68:1453-1460.
28. Brady AJ, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 1992;263:H1963-H1966.
29. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol. 1992;148:2724-2730.
30. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 1993;364:798-802.
31. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, Sipe JD, Shaw AR, Dinarello CA. Effect of endotoxin in IL-1 beta-deficient mice. J Immunol. 1996;157:291-296.
32. Szabo C, Thiemermann C, Wu CC, Perretti M, Vane JR. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A. 1994;91:271-275.
33. Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes: characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem. 1994;269:27580-27588.
34. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 1995;270:14582-14586.
35. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
36. 2+- independent nitric oxide synthase in the myocardium. Br J Pharmacol. 1992;105:575-580.
37. 2+ in cardiac myocytes. Circ Res. 1992;71:870-882.
38. Blumenthal DK, Stull JT, Gill GN. Phosphorylation of cardiac troponin by guanosine 3′:5′-monophosphate-dependent protein kinase. J Biol Chem. 1978;253:324-326.
39. Lincoln TM, Corbin JD. Purified cyclic GMP-dependent protein kinase catalyzes the phosphorylation of cardiac troponin inhibitory subunit (TN-1). J Biol Chem. 1978;253:337-339.
40. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun. 1987;142:436-440.
41. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990;87:1620-1624.
42. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J. S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci. U S A. 1992;89:444-448.
43. Oddis CV, Finkel MS. Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem Biophys Res Commun. 1995;213:1002-1009.
44. Depre C, Vanoverschelde JL, Goudemant JF, Mottet I, Hue L. Protection against ischemic injury by nonvasoactivc concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation. 1995;92:1911-1918